Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

Summary

The purpose of this study is to assess the effectiveness of JNJ-18054478 measured by the percent change from baseline in Forced Expiratory Volume in one Second (FEV1) after 12 weeks of therapy in patients with persistent asthma.

Timeline

Start

2007-07

Primary completion

2008-07

Completion

2008-07

Outcome

Outcome not reported

Stopped: “Lack of efficacy following an interim analysis”

Drugs

Indications